Home > Annual Financials > DIVIS LABORATORIES

DIVIS LABORATORIES Financial Statement Analysis
[BOM: 532488|NSE : DIVISLAB]

The Revenues of DIVIS LABORATORIES have increased by 28.56% YoY .
The Earnings Per Share (EPS) of DIVIS LABORATORIES has increased by 49.20 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

DIVIS LABORATORIES Last 5 Annual Financial Results
[BOM: 532488|NSE : DIVISLAB]

ConsolidatedMar2022
Mar2021
Mar2020
Mar2019
Mar2018
Revenues ₹8,960 Cr₹6,969 Cr₹5,394 Cr₹4,946 Cr₹3,891 Cr
Expenses ₹5,079 Cr₹4,108 Cr₹3,571 Cr₹3,073 Cr₹2,629 Cr
Operating Profit (Excl OI) ₹3,881 Cr₹2,861 Cr₹1,823 Cr₹1,873 Cr₹1,263 Cr
Other Income ₹116 Cr₹63 Cr₹190 Cr₹156 Cr₹113 Cr
Interest ₹2.00 Cr₹2.10 Cr₹7.14 Cr₹4.68 Cr₹2.37 Cr
Depreciation ₹312 Cr₹256 Cr₹186 Cr₹169 Cr₹142 Cr
Profit Before Tax ₹3,684 Cr₹2,666 Cr₹1,819 Cr₹1,855 Cr₹1,231 Cr
Profit After Tax ₹2,960 Cr₹1,984 Cr₹1,377 Cr₹1,353 Cr₹877 Cr
Consolidated Net Profit ₹2,960 Cr₹1,984 Cr₹1,377 Cr₹1,353 Cr₹877 Cr
Earnings Per Share (Rs)₹111.53₹74.75₹51.86₹50.96₹33.04
PAT Margin (%)32.9428.3825.2327.1522.41
ROE(%)28.1623.9019.3021.0015.55
ROCE(%)35.0632.0725.3628.5021.68
Total Debt/Equity(x)0.000.000.000.020.01

Key Financials

Market Cap : ₹ 98,983.7 Cr
Revenue (TTM) : ₹ 9,253.7 Cr
Net Profit(TTM) : ₹ 3,105.4 Cr
EPS (TTM) : ₹ 117.0
P/E (TTM) : 31.9

Industry Peers & Returns1W1M1Y
DIVIS LABORATORIES -4.7% -1.3% -19.7%
SUN PHARMACEUTICAL INDUSTRIES -0.2% 6.2% 16%
DR REDDYS LABORATORIES 2.6% -5.4% -11%
CIPLA -0.7% 7.8% 13.8%
GLAND PHARMA 4.5% -3.4% -44.2%
PIRAMAL ENTERPRISES 11.2% 13.1% -31.4%
CADILA HEALTHCARE 8.3% 5.1% -33.9%
TORRENT PHARMACEUTICALS -1.1% 3.5% 1.4%
ALKEM LABORATORIES -4.9% -5.7% -16.6%


DIVIS LABORATORIES Revenues
[BOM: 532488|NSE : DIVISLAB]

Y-o-Y

28.56 %

5 Yr CAGR

23.18 %

Years Revenues % Change
Mar2022 ₹8,960 Cr
28.56
Mar2021 ₹6,969 Cr
29.20
Mar2020 ₹5,394 Cr
9.06
Mar2019 ₹4,946 Cr
27.10
Mar2018 ₹3,891 Cr -


DIVIS LABORATORIES Operating Profit
[BOM: 532488|NSE : DIVISLAB]

Y-o-Y

35.65 %

5 Yr CAGR

32.41 %

Years Operating Profit % Change
Mar2022 ₹3,881 Cr
35.65
Mar2021 ₹2,861 Cr
56.92
Mar2020 ₹1,823 Cr
-2.66
Mar2019 ₹1,873 Cr
48.33
Mar2018 ₹1,263 Cr -

Operating Margins
Y-o-Y

5.53 %

5 Yr CAGR

7.49 %

Years Operating Margin% % Change
Mar2022 43.32%
5.53
Mar2021 41.05%
21.45
Mar2020 33.8%
-10.75
Mar2019 37.87%
16.70
Mar2018 32.45% -

DIVIS LABORATORIES Profit After Tax
[BOM: 532488|NSE : DIVISLAB]

Y-o-Y

49.19 %

5 Yr CAGR

35.55 %

Years Profit After Tax % Change
Mar2022 ₹2,960 Cr
49.19
Mar2021 ₹1,984 Cr
44.15
Mar2020 ₹1,377 Cr
1.76
Mar2019 ₹1,353 Cr
54.24
Mar2018 ₹877 Cr -

PAT Margins
Y-o-Y

16.07 %

5 Yr CAGR

10.11 %

Years PAT Margin(%) % Change
Mar2022 32.94 %
16.07
Mar2021 28.38 %
12.49
Mar2020 25.23 %
-7.07
Mar2019 27.15 %
21.15
Mar2018 22.41 % -

DIVIS LABORATORIES Earnings Per Share (EPS)
[BOM: 532488|NSE : DIVISLAB]

Y-o-Y

49.20 %

5 Yr CAGR

35.55 %

Years EPS % Change
Mar2022 ₹112
49.20
Mar2021 ₹75
44.14
Mar2020 ₹52
1.77
Mar2019 ₹51
54.24
Mar2018 ₹33 -

DIVIS LABORATORIES Return on Capital Employed (ROCE)
[BOM: 532488|NSE : DIVISLAB]

Y-o-Y

9.32 %

5 Yr CAGR

12.77 %

Years ROCE % Change
Mar2022 35.06%
9.32
Mar2021 32.07%
26.46
Mar2020 25.36%
-11.02
Mar2019 28.5%
31.46
Mar2018 21.68% -

DIVIS LABORATORIES Share Price vs Sensex

Current Share Price : ₹3,728.2
Current MarketCap: ₹ 98,983.7 Cr
Updated EOD on :Aug 12,2022

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

-4.7%

-1.3%

-19.7%

SENSEX

2%

10.4%

9.3%

DIVIS LABORATORIES related INDICES

BSE Indices1W1M1Y
S&P BSE SENSEX50 1.9% 10.3% 9.1%
S&P BSE LARGECAP 1.9% 10.2% 9.8%
S&P BSE 100 1.8% 10.2% 9.3%
S&P BSE 250 LARGEMIDCAP 1.8% 10.1% 9.4%
S&P BSE CARBONEX 1.8% 9.9% 9.2%
NSE Indices1W1M1Y
NIFTY 50 1.8% 10.2% 8.9%
NIFTY LARGE MIDCAP 250 1.8% 10.3% 9.9%
NIFTY 200 1.8% 10.1% 9.2%
NIFTY 100 1.7% 10% 8.9%
NIFTY 500 1.7% 9.9% 8.7%

You may also like the below Video Courses


FAQ about DIVIS LABORATORIES Financials


How the annual revenues of DIVIS LABORATORIES have changed ?

The Revenues of DIVIS LABORATORIES have increased by 28.56% YoY .

How the Earnings per Share (EPS) of DIVIS LABORATORIES have changed?

The Earnings Per Share (EPS) of DIVIS LABORATORIES has increased by 49.20 % YoY .



SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].